Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maurice Laville

Showing results (1-10 of 136) with videos related to

Pageof 14
Sort By:
La Revue Du Praticien|April 16, 2019
[From what initial assessment of renal function seek advice from the nephrologist?]Maurice Laville
Nephrologie & Therapeutique|January 7, 2011
[Renal consequences of obesity]Maurice Laville
Annals of Internal Medicine|November 16, 2011
ACP Journal Club. Simvastatin plus ezetimibe reduced major atherosclerotic events in patients with chronic kidney diseaseMaurice Laville
ACP Journal Club|January 20, 2005
Loop diuretics and angiotensin-converting enzyme inhibitors increased risk for hospitalization for lithium toxicityMaurice Laville
ACP Journal Club|February 7, 2002
Review: low-dose dopamine does not prevent acute renal failure or reduce mortality or need for hemodialysisMaurice Laville
Kidney International|March 22, 2021
Back off to better blow up: acute GFR decrease at SGLT-2 inhibitor initiationMaurice Laville
Nephrologie & Therapeutique|January 21, 2011
[Efficacy and safety of lanthanum carbonate in chronic kidney disease patients with hyperphosphataemia]Maurice Laville
La Revue Du Praticien|June 30, 2004
[Hypertension in patients with chronic renal disease]Maurice Laville
ACP Journal Club|September 5, 2003
Acetylcysteine prevented acute deterioration in renal function after coronary angiography in moderate renal insufficiencyMaurice Laville
ACP Journal Club|January 4, 2008
Review: effectiveness of ACE inhibitors is similar across various baseline risks for disease progression in nondiabetic nephropathyMaurice Laville
Pageof 14

Showing results (1-10 of 136) with videos related to

Sort By:
Pageof 14
La Revue Du Praticien|April 16, 2019
[From what initial assessment of renal function seek advice from the nephrologist?]Maurice Laville
Nephrologie & Therapeutique|January 7, 2011
[Renal consequences of obesity]Maurice Laville
Annals of Internal Medicine|November 16, 2011
ACP Journal Club. Simvastatin plus ezetimibe reduced major atherosclerotic events in patients with chronic kidney diseaseMaurice Laville
ACP Journal Club|January 20, 2005
Loop diuretics and angiotensin-converting enzyme inhibitors increased risk for hospitalization for lithium toxicityMaurice Laville
ACP Journal Club|February 7, 2002
Review: low-dose dopamine does not prevent acute renal failure or reduce mortality or need for hemodialysisMaurice Laville
Kidney International|March 22, 2021
Back off to better blow up: acute GFR decrease at SGLT-2 inhibitor initiationMaurice Laville
Nephrologie & Therapeutique|January 21, 2011
[Efficacy and safety of lanthanum carbonate in chronic kidney disease patients with hyperphosphataemia]Maurice Laville
La Revue Du Praticien|June 30, 2004
[Hypertension in patients with chronic renal disease]Maurice Laville
ACP Journal Club|September 5, 2003
Acetylcysteine prevented acute deterioration in renal function after coronary angiography in moderate renal insufficiencyMaurice Laville
ACP Journal Club|January 4, 2008
Review: effectiveness of ACE inhibitors is similar across various baseline risks for disease progression in nondiabetic nephropathyMaurice Laville
Pageof 14